Trials News and Press Releases DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years Access the press release here. LEO Pharma Announces Health Canada Approval of Anzupgo® for Treatment of Moderate to Severe Chronic Hand Eczema Access the press release here.
